Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             147 results found
no title author magazine year volume issue page(s) type
1 Abstracts of the 47th A.I.S.F. – Italian Association for the Study of the Liver – Annual Meeting 2014 2014
 46 S1 p. e70-
1 p.
 article
2 A cost-consequence analysis of screening and treatment for chronic hepatitis B (CHB) virus infection in resident immigrants of an Italian North-East Rosa-Rizzotto, E.
 2014
 46 S1 p. e23-
1 p.
 article
3 Activation of the developmental pathway Ngn-3/miR-7a regulates cholangiocytes proliferation in response to injury Marzioni, M.
 2014
 46 S1 p. e3-
1 p.
 article
4 Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: A real life cross-sectional study Morando, F.
 2014
 46 S1 p. e33-
1 p.
 article
5 Adult human biliary tree stem cells (hBTSCs) are efficiently reprogrammed to functional insulin-secreting β-pancreatic islet cells by a newly synthesized human Pdx1 peptide Cardinale, V.
 2014
 46 S1 p. e4-
1 p.
 article
6 AKIN vs conventional criteria to diagnose pre-liver transplant acute kidney injury: Gender differences and outcome post-LT Fiacco, F.
 2014
 46 S1 p. e61-e62
nvt p.
 article
7 Alteration in glucose metabolism after an oral glucose load in patients with non-alcoholic fatty liver disease Vanni, E.
 2014
 46 S1 p. e54-
1 p.
 article
8 Alteration in lipid metabolism after an oral fat load in non-alcoholic fatty liver disease Mezzabotta, L.
 2014
 46 S1 p. e53-e54
nvt p.
 article
9 Angiogenesis in chronic hepatitis C recurring after liver transplantation is correlated with splancnic hemodinamics Pizzi, M.
 2014
 46 S1 p. e67-
1 p.
 article
10 A novel simplified Child-Turcotte-Pugh score for prognostic assessment and therapeutic decision in patients with hepatocellular carcinoma A.Vitale,
 2014
 46 S1 p. e5-
1 p.
 article
11 Antagonistic signalling by PPARgamma and rosiglitazone converge on Ruvbl1 regulation in HCC cells Mello, T.
 2014
 46 S1 p. e38-
1 p.
 article
12 Appearance of combined hepatocellular cholangiocarcinoma in cirrhosis at contrast enhanced imaging techniques Sagrini, E.
 2014
 46 S1 p. e17-
1 p.
 article
13 A regret-based approach to choose between trans-catheter arterial embolization and hepatic resection for intermediate hepatocellular carcinoma Cucchetti, A.
 2014
 46 S1 p. e16-
1 p.
 article
14 Association of IFNL4 genotype and ALT decrease is a new tool to predict viral eradication in HCV Sardinian patients with chronic hepatitis C, genotype 4, treated with PEG-IFNα and Ribavirin Chessa, L.
 2014
 46 S1 p. e48-e49
nvt p.
 article
15 Barcelona Clinic Liver Cancer staging and the net benefit of liver resection for patients with hepatocellular carcinoma: a multicentre, cohort study Vitale, A.
 2014
 46 S1 p. e15-e16
nvt p.
 article
16 Bleeding-unrelated mortality is not increased in patients with cirrhosis and ascites on treatment with β-blockers: A meta-analysis Ferrarese, A.
 2014
 46 S1 p. e31-
1 p.
 article
17 Cannabinoid receptor 2-63 Qq variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C Coppola, N.
 2014
 46 S1 p. e21-
1 p.
 article
18 Caspase-3 targeting: A further tile sustaining the anti-apoptotic role of miR-221 in hepatocellular carcinoma Fornari, F.
 2014
 46 S1 p. e6-
1 p.
 article
19 Changes in serum levels of asymmetric-dimethylarginine (ADMA) in a rat model of non-alcoholic steatohepatitis: Role of oxidative stress Ferrigno, A.
 2014
 46 S1 p. e27-e28
nvt p.
 article
20 Cholangiocarcinoma (CCA) express chemokine receptor CXCR7: Important role of CXCR7 in mediating CXCL12 induced CCA cells chemotaxis and survival Gentilini, A.
 2014
 46 S1 p. e37-
1 p.
 article
21 Chronic hepatitis B patients developing tubular dysfunction during long-term tenofovir treatment can be successfully and safely rescued by entecavir Mangia, G.
 2014
 46 S1 p. e24-
1 p.
 article
22 Chronic treatment with betablockers for the management of portal hypertension: A multi-center cross-sectional study in elderly patients with cirrhosis La Mura, V.
 2014
 46 S1 p. e32-
1 p.
 article
23 Coffee enhances the expression of mitochondrial and endoplasmic reticulum chaperones in rats with steatohepatitis Salomone, F.
 2014
 46 S1 p. e27-
1 p.
 article
24 Concomitant versus sequential treatment with TACE and sorafenib in HCC patients Sacco, R.
 2014
 46 S1 p. e37-
1 p.
 article
25 Cost-efficacy analysis of chronic hepatitis B treatment in a real-life setting of the Northern-Italy Pecere, S.
 2014
 46 S1 p. e22-e23
nvt p.
 article
26 c-Rel and p27Kip are downstream targets of ERK5 in hepatocellular carcinoma (HCC) in vivo and in vitro Di Maira, G.
 2014
 46 S1 p. e37-e38
nvt p.
 article
27 Does the gut microbiota modulate the inflammatory state in cirrhotic host? Di Gregorio, V.
 2014
 46 S1 p. e34-
1 p.
 article
28 Does ultra-deep-sequencing in HCV patients treated with boceprevir/telaprevir-based therapy provide an added value in comparison to standard population-sequencing in the detection of resistance? Di Maio, V.C.
 2014
 46 S1 p. e47-e48
nvt p.
 article
29 3D-Speckle Tracking Echocardiography in cirrhotic patients: A possible tool for the diagnosis of cirrhotic cardiomyopathy Iacovone, G.
 2014
 46 S1 p. e62-
1 p.
 article
30 Dysregulation of microRNA expression in PBMCs from patients with HCV-related malignancies Piluso, A.
 2014
 46 S1 p. e15-
1 p.
 article
31 Early menopausal status is associated with the severity of liver fibrosis in Italian patients with non-alcoholic fatty liver disease Petta, S.
 2014
 46 S1 p. e25-e26
nvt p.
 article
32 Early prediction of sustained virologic response by HCV Core Ag kinetics in chronic hepatitis C patients treated with Peginterferon plus Ribavirin Ricco, G.
 2014
 46 S1 p. e46-
1 p.
 article
33 Early viral dynamics in HCV-RNA decay and NS3-resistance development predict the risk of failure to first-generation protease inhibitors Cento, V.
 2014
 46 S1 p. e45-
1 p.
 article
34 Early virological response is the main predictors of viral eradication in HCV haemodialysis patients treated with pegylated interferon plus ribavirin Tucci, A.
 2014
 46 S1 p. e13-
1 p.
 article
35 Effect of portal vein thrombosis (PVT) on survival after liver transplantation (LT): A meta-analysis Zanetto, A.
 2014
 46 S1 p. e67-e68
nvt p.
 article
36 Effects of glucose and fat load on oxidative stress in patients with non-alcoholic fatty liver disease Rosso, C.
 2014
 46 S1 p. e54-
1 p.
 article
37 Effects of Non-Selective β-Blockers on hemodynamic and Paracentesis Induced Circulatory Dysfunction in cirrhotics undergoing large volume paracentesis Ferrarese, A.
 2014
 46 S1 p. e59-
1 p.
 article
38 Efficacy and safety of Boceprevir-based therapy in HCVG1 treatment-experienced patients with advanced fibrosis/cirrhosis: Italian NPP survey Bruno, S.
 2014
 46 S1 p. e12-
1 p.
 article
39 Eligibility 2: A prospective, observational, multicentre study on outcomes of peg-interferon/ribavirin (Peg-IFN/RBV) in chronic hepatitis C (CHC) Vukotic, R.
 2014
 46 S1 p. e45-e46
nvt p.
 article
40 Eligibility 1: A prospective study evaluating HCV patients’ characteristics of eligibility for antiviral therapy in real clinical practice Gamal, N.
 2014
 46 S1 p. e46-e47
nvt p.
 article
41 Endocannabinoids and liver cirrhosis: The endocannabinoid-related molecule oleoyl-ethanolamine (OEA) correlates with clinical complications and 1-year survival Baldassarre, M.
 2014
 46 S1 p. e33-
1 p.
 article
42 Enhancer of Zeste Homolog 2 (EZH2) expression and activation in in vivo and in vitro non-alcoholic fatty liver disease (NAFLD) Gnani, D.
 2014
 46 S1 p. e28-
1 p.
 article
43 Enrichment in novel rare coding variants of Telomerase gene in hepatocellular carcinoma patients with NASH related cirrhosis Donati, B.
 2014
 46 S1 p. e14-e15
nvt p.
 article
44 Entecavir effectiveness in naïve and NUC experienced patients: Interim analysis of the ENTAS cohort study of patients with chronic hepatitis B Porro, E.
 2014
 46 S1 p. e50-e51
nvt p.
 article
45 Epicardial fat thickness (EAT) in patients with nonalcoholic fatty liver disease (NAFLD) is associated with markers of cardiovascular damage and severity of steatosis Pisano, G.
 2014
 46 S1 p. e3-e4
nvt p.
 article
46 Epidemiological evolution of Chronic Hepatitis Delta in Italy. An analysis of the Master-B cohort Brancaccio, G.
 2014
 46 S1 p. e12-e13
nvt p.
 article
47 Epigenetic changes associated with the induction of vesicular steatosis in an in vitro cellular model Pediconi, N.
 2014
 46 S1 p. e56-
1 p.
 article
48 Epigenetic drugs targeting cccDNA-bound chromatin modifying enzymes silence HBV transcription and inhibit viral replication Palumbo, G.A.
 2014
 46 S1 p. e25-
1 p.
 article
49 Evidence of an iperactivation of inflammasome in peripheral blood mononucleated cells of patients with acute on chronic liver failure Gola, E.
 2014
 46 S1 p. e61-
1 p.
 article
50 FcγRIIIa shedding from NK cells does not impair antibody-dependent cellular cytotoxicity in chronic HCV infection Oliviero, B.
 2014
 46 S1 p. e49-
1 p.
 article
51 First-line treatment of 90 consecutive HCC with drug eluting beads chemoembolization (DEB-TACE) Triolo, M.
 2014
 46 S1 p. e64-
1 p.
 article
52 Four years of tenofovir monotherapy for NUC naïve field practice European patients suppresses HBV replication in most patients with a favorable renal safety profile but does not prevent HCC in patients with or without cirrhosis Lampertico, P.
 2014
 46 S1 p. e14-
1 p.
 article
53 Genotype 3 and circulating SCCA-IgM are independently associated with histological features of NASH in HCV infected patients Martini, A.
 2014
 46 S1 p. e26-
1 p.
 article
54 HAPs hepatitis B virus (HBV) capsid inhibitors prevent HBc interaction with the viral minichromosome and selected host cell genes to inhibits transcription and affect cccDNA stability Belloni, L.
 2014
 46 S1 p. e9-
1 p.
 article
55 HBsAg genetic elements critical for immune escape correlates with HBV reactivation upon immunosuppression Salpini, R.
 2014
 46 S1 p. e11-
1 p.
 article
56 HBx directly mediates deregulation of several ncRNAs identified by ChIP-Seq experiment Guerrieri, F.
 2014
 46 S1 p. e25-
1 p.
 article
57 HCV genotype 1a and 1b: Similarities and differences in clinical features, therapeutic outcome and predictors of response Morisco, F.
 2014
 46 S1 p. e44-
1 p.
 article
58 HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV-HCV co-infected patients: A 3-years follow-up study Basso, M.
 2014
 46 S1 p. e48-
1 p.
 article
59 Hemostatic status and portal vein thrombosis (PVT) in cirrhotic patients with hepatocellular carcinoma (HCC) Zanetto, A.
 2014
 46 S1 p. e36-
1 p.
 article
60 Hepatitis B virus screening in healthy immigrants: A strategy to prevent the spread of infection and to identify and manage chronic hepatitis B (CHB) Peraro, L.
 2014
 46 S1 p. e52-
1 p.
 article
61 Hepatitis C virus in healthy immigrants: To screen or not to screen? Peraro, L.
 2014
 46 S1 p. e18-e19
nvt p.
 article
62 High donor-age vs High MELD in liver Tx. Which is the most effective approach? Evidences from the Italy-US D-MELD study Avolio, A.W.
 2014
 46 S1 p. e7-e8
nvt p.
 article
63 High rates of tenofovir dose adjustments are required in Adefovir experienced patients with chronic hepatitis B: A 4-year prospective study in 320 patients Lampertico, P.
 2014
 46 S1 p. e49-
1 p.
 article
64 Human biliary tree stem/progenitor cells (hBTSCs) from peribiliary glands (PBGs) of adult liver display immunomodulatory properties through Fas/Fas ligand induced T-cell lymphocyte apoptosis Carnevale, G.
 2014
 46 S1 p. e30-
1 p.
 article
65 Human cholangiocarcinoma (CCA) and CCA cancer stem cells (CSCs) are highly sensitive to the antiproliferative effects of PI3-kinase inhibitors Fraveto, A.
 2014
 46 S1 p. e2-
1 p.
 article
66 Immuno-modulating effects of Silibinin in liver transplant patients with HCV recurrence Castellaneta, A.
 2014
 46 S1 p. e67-
1 p.
 article
67 Impact of mTOR inhibition on expression of immune regulatory molecules by circulating dendritic cells and regulatory T cells in stable liver transplant patients Castellaneta, A.
 2014
 46 S1 p. e8-
1 p.
 article
68 Incidence and risk factors for extra-hepatic malignancies in primary biliary cirrhosis: A comparative study from two European referral centers Cazzagon, N.
 2014
 46 S1 p. e29-
1 p.
 article
69 Inhibition of indoleamine 2,3-dioxygenase ameliorates inflammation and fibrosis in experimental steatohepatitis Vivoli, E.
 2014
 46 S1 p. e29-
1 p.
 article
70 Inosine triphosphatase deficiency does not predict anemia severity nor anemia management in patients with advanced fibrosis receiving telaprevir Grassi, E.
 2014
 46 S1 p. e20-
1 p.
 article
71 Intraoperative histological ischemia–reperfusion injury assessment but not clinical early allograft dysfunction predicts graft loss only in HCV positive recipients submitted to liver transplant Ginanni Corradini, S.
 2014
 46 S1 p. e39-
1 p.
 article
72 Ischemia modified albumin (IMA) for the diagnosis of bacterial infection in hospitalized patients with cirrhosis Giannone, F.A.
 2014
 46 S1 p. e32-
1 p.
 article
73 Is the vasopressin release the crucial factor in the pathogenesis of hypervolemic hyponatremia in patients with cirrhosis and ascites? Piano, S.
 2014
 46 S1 p. e60-
1 p.
 article
74 Italian survey on HBV and liver transplantation in a cohort of 2260 patients Fasulo, R.
 2014
 46 S1 p. e8-e9
nvt p.
 article
75 Key genetic markers in the full-length HBsAg gene correlate with HBV-driven carcinogenesis by affecting HBsAg secretion and release Svicher, V.
 2014
 46 S1 p. e53-
1 p.
 article
76 Leukaemia inhibitory factor protects cholangiocarcinoma cells from cytotoxicity via a STAT-3-independent, Mcl-1 activation Morton, S.D.
 2014
 46 S1 p. e65-
1 p.
 article
77 Linkage between interferon-λ4 and IL28B polymorphisms in HCV-4 patients treated with pegylated interferon and ribavirin De Nicola, S.
 2014
 46 S1 p. e21-
1 p.
 article
78 Liver investigation: A possible new tool for cardiovascular risk evaluation Viscomi, C.
 2014
 46 S1 p. e56-e57
nvt p.
 article
79 Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: A case match analysis Gringeri, E.
 2014
 46 S1 p. e39-
1 p.
 article
80 Liver transplantation in cirrhotic patients with portal vein thrombosis: A single centre experience Risso, A.
 2014
 46 S1 p. e40-
1 p.
 article
81 Long term NUC treatment in hepatitis B virus HBeAg negative genotype D patients and risk for hepatocellular carcinoma: Evidence from the CLEO cohort study Pellicelli, A.M.
 2014
 46 S1 p. e24-
1 p.
 article
82 Long-term outcome of inactive and low viremic HBeAg negative active carriers: Benign one direction transition towards spontaneous HBsAg clearance Surace, L.
 2014
 46 S1 p. e13-
1 p.
 article
83 Low accuracy of non-invasive tests for assessing residual cirrhosis in hepatitis C patients with a sustained virological response Degasperi, E.
 2014
 46 S1 p. e16-
1 p.
 article
84 Low risk of hepatitis B virus reactivation in HBsAg negative, anti-HBc positive carriers undergoing rituximab for rheumatoid arthritis Viganò, M.
 2014
 46 S1 p. e23-
1 p.
 article
85 Lymphocytes as liver damage mirror of HCV related adipogenesis deregulation Minutolo, A.
 2014
 46 S1 p. e22-
1 p.
 article
86 Lysosomes involvement in chemoresistance of hepatocellular carcinoma cells Trombetta, E.
 2014
 46 S1 p. e65-e66
nvt p.
 article
87 Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis Cortesi, P.A.
 2014
 46 S1 p. e11-
1 p.
 article
88 Management of infectious mixed cryoglobulinemia: Clinical outcome of 246 patients Mauro, E.
 2014
 46 S1 p. e18-
1 p.
 article
89 Marginal liver grafts characterization: (1) Imaging and in situ spectral analysis of Nile Red-induced lipid fluorescence in MCD-induced liver steatosis Tarantola, E.
 2014
 46 S1 p. e55-
1 p.
 article
90 Marginal liver grafts characterization: (2) In situ evaluation of oxidative stress in liver steatosis induced by MCD Boncompagni, E.
 2014
 46 S1 p. e56-
1 p.
 article
91 MERTK rs4374383 AA genotype is associated with a lower prevalence of severe hepatic steatosis in non-alcoholic fatty liver disease Petta, S.
 2014
 46 S1 p. e2-
1 p.
 article
92 Microinvasive intraoperative ultrasound pattern in predicting outcomes for single small (<3cm) hepatocellular carcinoma Santambrogio, R.
 2014
 46 S1 p. e66-
1 p.
 article
93 Microparticles released as a consequence of lipid-induced toxicity promote NLRP3 inflammasome activation in HepG2 cells Paternostro, C.
 2014
 46 S1 p. e1-
1 p.
 article
94 Missense variant in interferon-λ4 gene identifies HCV-1 infected patients carrying the unfavorable IL28B (T) allele with improved viral kinetics Galmozzi, E.
 2014
 46 S1 p. e22-
1 p.
 article
95 Mortality prediction with transient elastography after liver transplantation for liver failure of various aetiologies Sagrini, E.
 2014
 46 S1 p. e58-
1 p.
 article
96 Non-Invasive Score system for Fibrosis (NISF): A new staging model combining biochemical, elastographic and ultrasound data in chronic liver disease Campion, D.
 2014
 46 S1 p. e3-
1 p.
 article
97 NOX2-generated oxidative stress is increased in patients with non-alcoholic fatty liver disease independently from metabolic syndrome Baratta, F.
 2014
 46 S1 p. e27-
1 p.
 article
98 Obstructive sleep apnea syndrome in non-severely obese patients with NAFLD Pulixi, E.A.
 2014
 46 S1 p. e55-
1 p.
 article
99 Optimizing results of liver transplantation with graft from HBcAb positive donor Tandoi, F.
 2014
 46 S1 p. e40-
1 p.
 article
100 Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) Okolicsanyi, S.
 2014
 46 S1 p. e7-
1 p.
 article
101 Oxygen gradient on a chip for optimizing the differentiation of human pluripotent stem cells into hepatic cells Tonon, F.
 2014
 46 S1 p. e42-
1 p.
 article
102 PAF-receptor antagonists reduce HCC progression blocking cancer cell proliferation and migration Tarocchi, M.
 2014
 46 S1 p. e66-
1 p.
 article
103 Pathogenesis of solute-free water retention in experimental ascitic cirrhosis: Is vasopressin (ADH) the only agent to blame? Sansoè, G.
 2014
 46 S1 p. e34-e35
nvt p.
 article
104 Peg-interferon and ribavirin therapy is safe and effective among HCV patients with thalassaemia major D’Ambrosio, R.
 2014
 46 S1 p. e19-
1 p.
 article
105 Peg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: A meta-analysis on role of response predictors Coppola, N.
 2014
 46 S1 p. e19-e20
nvt p.
 article
106 Pharmacokinetics of sunitinib in patients with liver cirrhosis and hepatocellular carcinoma Biolato, M.
 2014
 46 S1 p. e64-e65
nvt p.
 article
107 PNPLA3 rs738409 C>G SNP is associated with histological features of NASH in genotype 1 chronic hepatitis C patients Petta, S.
 2014
 46 S1 p. e19-
1 p.
 article
108 Point quantification elastography as a noninvasive technique for quantification of liver fibrosis Fiorini, E.
 2014
 46 S1 p. e58-e59
nvt p.
 article
109 Polycomb protein enhancer of Zeste Homolog 2 (EZH2) protects human hepatocellular carcinoma (HCC) cells from DNA damage response (DDR) associated apoptosis Salerno, D.
 2014
 46 S1 p. e38-
1 p.
 article
110 Portal hypertension but not HCC risk is attenuated in compensated cirrhotics following 10 years of treatment with nucleos(t)ide analogs Invernizzi, F.
 2014
 46 S1 p. e50-
1 p.
 article
111 Post sorafenib survival in patients with advanced hepatocellular carcinoma: The role of tumor progression and liver impairment Iavarone, M.
 2014
 46 S1 p. e35-e36
nvt p.
 article
112 Prediction of EVS presence by calculated risk scores in B—Viral cirrhosis Marietti, M.
 2014
 46 S1 p. e60-
1 p.
 article
113 Pregnancy and primary biliary cirrhosis: A case–control study Franceschet, I.
 2014
 46 S1 p. e57-
1 p.
 article
114 Preliminary experience of treatment with Teriparatide of post-OLT severe osteoporosis unresponsive to standard therapy Valente, G.
 2014
 46 S1 p. e68-
1 p.
 article
115 Progression of early atherosclerotic vascular damage in patients with NAFLD and in controls of general population during 10 years of follow up Porzio, M.
 2014
 46 S1 p. e26-
1 p.
 article
116 PRO-inflammatory and pro-fibrogenic actions of the HIV-envelope protein gp120 are mediated by inflammasome activation and MIR29B Cappon, A.
 2014
 46 S1 p. e1-e2
nvt p.
 article
117 Prophylaxis strategy to prevent HBV-reactivation in oncologic immunosuppressed patients: Results of guidelines-based on-field practice Sangiovanni, L.
 2014
 46 S1 p. e51-
1 p.
 article
118 P53 status affects copper homeostasis in experimental model of hepatic steatosis Arciello, M.
 2014
 46 S1 p. e28-e29
nvt p.
 article
119 Quantification of fibrosis in chronic hepatitis C: Performance of Transient Elastography and Acoustic Radiation Force Impulse using Collagen Proportionate Area as reference Calvaruso, V.
 2014
 46 S1 p. e58-
1 p.
 article
120 Reactivation of hepatitis B virus in HBsAg-negative HBcAb-positive patients with psoriasis undergoing immunosuppressive therapy Morisco, F.
 2014
 46 S1 p. e51-
1 p.
 article
121 Recipient and donor gender match predicts the outcome of antiviral therapy for recurrent hepatitis C Bitetto, D.
 2014
 46 S1 p. e41-
1 p.
 article
122 Reinfusion of highly purified CD133+ stem cells in patients with End-Stage Liver Disease (ESLD): Final results of a phase I clinical trial Margini, C.
 2014
 46 S1 p. e6-e7
nvt p.
 article
123 Renal effects of different doses of α2-adrenergic agonists, alone or in combination with diuretics, in rats with experimental cirrhosis and ascites Sansoè, G.
 2014
 46 S1 p. e62-
1 p.
 article
124 Resistance to thrombomodulin is associated with de novo portal vein thrombosis and could be a modifiable factor to improve prognosis in cirrhosis La Mura, V.
 2014
 46 S1 p. e31-
1 p.
 article
125 Results of surgical treatment of hepatocellular carcinoma in patients with metabolic syndrome as unique oncological risk factor Ajani, C.
 2014
 46 S1 p. e35-
1 p.
 article
126 Role of sialic-acid-binding immunoglobulin-like lectin-7 (siglec-7) as biomarker of liver disease severity in chronic HCV infection Varchetta, S.
 2014
 46 S1 p. e10-
1 p.
 article
127 SCCA-IgM is predictive of hepatocellular carcinoma development in patients with HCV cirrhosis—A prospective study Biasiolo, A.
 2014
 46 S1 p. e61-
1 p.
 article
128 Sex hormones differently regulate hepatic hepcidin expression and systemic iron homeostasis in vivo Garuti, C.
 2014
 46 S1 p. e30-
1 p.
 article
129 SIRT1 activity in hepatic stellate cells during liver injury is a target for the modulation of the fibrogenic process Tarocchi, M.
 2014
 46 S1 p. e30-e31
nvt p.
 article
130 Sorafenib versus Y90-Radioembolization: A preliminary assessment of tolerability and survival in advanced mono-lobar hepatocellular carcinoma Cantamessa, A.
 2014
 46 S1 p. e64-
1 p.
 article
131 Spleen stiffness measurement by ARFI strongly predict the oesophageal varices stage and bleeding probability Bramuzzo, I.
 2014
 46 S1 p. e60-
1 p.
 article
132 Stem cell niche and macrophages in human cholangiocarcinoma Raggi, C.
 2014
 46 S1 p. e4-
1 p.
 article
133 SVR is associated with no risk reduction of HCC development in patients with HCV-related cirrhosis. A prospective, up-to 23 years, cohort follow-up study De Lisi, S.
 2014
 46 S1 p. e33-e34
nvt p.
 article
134 Symptomatic onset identifies a more aggressive subset of primary biliary cirrhosis Quarneti, C.
 2014
 46 S1 p. e5-
1 p.
 article
135 The AMPK-related kinase, Nuak2 is modulated by the activation process and regulates motility of hepatic stellate cells (HSC) Guerra, C. Tosti
 2014
 46 S1 p. e59-
1 p.
 article
136 The changing scenario of hepatocellular carcinoma in Italy: An update Lenzi, B.
 2014
 46 S1 p. e63-
1 p.
 article
137 The co-administration of telaprevir increases ribavirin plasma and intra-erythrocytic concentrations, causing higher onset of anemia De Nicolò, A.
 2014
 46 S1 p. e10-
1 p.
 article
138 The histological or ultrasonographic detection of steatosis affects the performance of LSM in patients with chronic HCV genotype 1 infection Macaluso, F.S.
 2014
 46 S1 p. e20-
1 p.
 article
139 The impact of IL-28B polymorphism and diabetes on SVR after antiviral therapy (AT) for post-liver transplant (LT) HCV recurrence Bitetto, D.
 2014
 46 S1 p. e41-
1 p.
 article
140 The inflammasome pathway as a target of berberine in experimental steatohepatitis and acetaminophen toxicity Vivoli, E.
 2014
 46 S1 p. e69-
1 p.
 article
141 The predictive role of Week 8 (RVRw8) viral kinetics in prior PR null responders receiving telaprevir in the delayed-start arm of the REALIZE trial Rumi, M.G.
 2014
 46 S1 p. e43-
1 p.
 article
142 The red cell distribution width (RDW) is a novel powerful, inexpensive predictor of survival for patients who present with hepatocellular carcinoma Grossi, G.
 2014
 46 S1 p. e36-
1 p.
 article
143 Thrombelastography (TEG) decreases blood products requirement before invasive procedures in cirrhotic patients with coagulation tests derangement. A randomized controlled trial De Pietri, L.
 2014
 46 S1 p. e5-e6
nvt p.
 article
144 Tumorigenic potential of cancer stem cells (CSCs) isolated from human cholangiocarcinoma (CCA) subtypes Torrice, A.
 2014
 46 S1 p. e57-
1 p.
 article
145 Usefulness of Acoustic Radiation Force Impulse (ARFI) in the assessment of liver fibrosis due to recurrent hepatitis C after liver transplantation Dissegna, D.
 2014
 46 S1 p. e68-
1 p.
 article
146 Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) Okolicsanyi, S.
 2014
 46 S1 p. e63-
1 p.
 article
147 Vitamin E as therapy for children with E antigen positive chronic hepatitis B: Results of a randomized controlled trial Fiorino, S.
 2014
 46 S1 p. e52-
1 p.
 article
                             147 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands